Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer

Basit Öğe Kaydı
dc.contributor.authorSezgin, Y.
dc.contributor.authorKarhan, O.
dc.contributor.authorUrakci, Z.
dc.contributor.authorMecidova, N.
dc.contributor.authorAraz, M.
dc.contributor.authorSakin, A.
dc.contributor.authorErcek, B. M.
dc.date.accessioned2025-07-03T21:25:02Z
dc.date.issued2024
dc.departmentBalıkesir Üniversitesi
dc.descriptionAnnual Congress of the European-Society-for-Medical-Oncology (ESMO) -- SEP 13-17, 2024 -- Barcelona, SPAIN
dc.description.abstract[No abstract available]
dc.description.sponsorshipEuropean Soc Med Oncol
dc.identifier.doi10.1016/j.annonc.2024.08.1586
dc.identifier.endpageS930
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.scopusqualityQ1
dc.identifier.startpageS930
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2024.08.1586
dc.identifier.urihttps://hdl.handle.net/20.500.12462/21324
dc.identifier.volume35
dc.identifier.wosWOS:001326612902145
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofAnnals of Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250703
dc.titleEfficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
dc.typeConference Object

Dosyalar

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu